能倍乐被证实可改善哮喘患者的呼吸症状

Asthma, COPD, and ACOS are common airway diseases with high incidence rates and heavy disease burden in my country. Chronic airway inflammation, airway obstruction, and airway hyperresponsiveness are their common pathophysiological changes. It is a commonly used M cholinergic receptor in clinical practice. It has the effect of relaxing bronchial smooth muscles and reducing the excitability of sympathetic nerves. It can relieve the fatigue of smooth muscles and relieve pulmonary ventilation. Respimat has been proven to improve the respiratory symptoms of asthma patients. I will introduce it to you below.

On May 23, 2017, Boehringer Ingelheim announced the results of a new analysis, providing further evidence that in a Phase III clinical development program, respiratory symptoms improved after the addition of tiotropium Respimat® (Sriva® Respimat®) in a population of patients whose asthma symptoms were not controlled on daily maintenance therapy.

The addition of Respimat improved lung function and asthma symptom control in children and adolescents compared with placebo, and improved airway obstruction in adults with symptomatic asthma, independent of body mass index (BMI). All analyzes showed that patients with previously uncontrolled asthma experienced improvement in their respiratory symptoms when adding Respimat to an ICS or ICS/LABA combination regimen.

Observed in the experiment were feelings of heartbeat (palpitations), headaches, high blood pressure, dizziness, difficulty sleeping (insomnia), irregular heartbeat (atrial fibrillation), rapid heartbeat (tachycardia), coughing, constipation, etc. During the period of using Respimat, it is recommended that patients take the medication strictly in accordance with the doctor's instructions to maximize the effect of Respimat. They must not change the medication time and dosage on their own. You must know that even if you increase the dosage of the drug, there is no way to improve the actual therapeutic effect of the drug. On the contrary, it may cause more adverse reactions, so do not use the drug blindly.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.